Protection of the brain through supplementation with larch arabinogalactan in a rat model of vascular dementia
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Vascular dementia (VaD) caused by reduced blood supply to the brain manifests as white matter lesions accompanying demyelination and glial activation. We previously showed that arabinoxylan consisting of arabinose and xylose, and arabinose itself attenuated white matter injury in a rat model of VaD. Here, we investigated whether larch arabinogalactan (LAG) consisting of arabinose and galactose could also reduce white matter injury. MATERIALS/METHODS: We used a rat model of bilateral common carotid artery occlusion (BCCAO), in which the bilateral common carotid arteries were exposed and ligated permanently with silk sutures. The rats were fed a modified AIN-93G diet supplemented with LAG (100 mg/kg/day) for 5 days before and 4 weeks after being subjected to BCCAO. Four weeks after BCCAO, the pupillary light reflex (PLR) was measured to assess functional consequences of injury in the corpus callosum (cc). Additionally, Luxol fast blue staining and immunohistochemical staining were conducted to assess white matter injury, and astrocytic and microglial activation, respectively. RESULTS: We showed that white matter injury in the the cc and optic tract (opt) was attenuated in rats fed diet supplemented with LAG. Functional consequences of injury reduction in the opt manifested as improved PLR. Overall, these findings indicate that LAG intake protects against white matter injury through inhibition of glial activation. CONCLUSIONS: The results of this study support our hypothesis that cell wall polysaccharides consisting of arabinose are effective at protecting white matter injury, regardless of their origin. Moreover, LAG has the potential for development as a functional food to prevent vascular dementia.
Abstract
BACKGROUND/OBJECTIVES: Vascular dementia (VaD) caused by reduced blood supply to the brain manifests as white matter lesions accompanying demyelination and glial activation. We previously showed that arabinoxylan consisting of arabinose and xylose, and arabinose itself attenuated white matter injury in a rat model of VaD. Here, we investigated whether larch arabinogalactan (LAG) consisting of arabinose and galactose could also reduce white matter injury. MATERIALS/METHODS: We used a rat model of bilateral common carotid artery occlusion (BCCAO), in which the bilateral common carotid arteries were exposed and ligated permanently with silk sutures. The rats were fed a modified AIN-93G diet supplemented with LAG (100 mg/kg/day) for 5 days before and 4 weeks after being subjected to BCCAO. Four weeks after BCCAO, the pupillary light reflex (PLR) was measured to assess functional consequences of injury in the corpus callosum (cc). Additionally, Luxol fast blue staining and immunohistochemical staining were conducted to assess white matter injury, and astrocytic and microglial activation, respectively. RESULTS: We showed that white matter injury in the the cc and optic tract (opt) was attenuated in rats fed diet supplemented with LAG. Functional consequences of injury reduction in the opt manifested as improved PLR. Overall, these findings indicate that LAG intake protects against white matter injury through inhibition of glial activation. CONCLUSIONS: The results of this study support our hypothesis that cell wall polysaccharides consisting of arabinose are effective at protecting white matter injury, regardless of their origin. Moreover, LAG has the potential for development as a functional food to prevent vascular dementia.
참고문헌 (47)
- Venkat P, "Models and mechanisms of vascular dementia", Exp Neurol, 272, pp.97~108 (2015)
- O'Brien JT, "Vascular dementia", Lancet, 386, pp.1698~1706 (2015)
- Iadecola C., "The pathobiology of vascular dementia", Neuron, 80, pp.844~866 (2013)
- Jiwa NS, "Experimental models of vascular dementia and vascular cognitive impairment: a systematic review", J Neurochem, 115, pp.814~828 (2010)
- Yamauchi H, "Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease", Arch Neurol, 50, pp.1070~1074 (1993)
- Lin CJ, "Intervention versus aggressive medical therapy for cognition in severe asymptomatic carotid stenosis", AJNR Am J Neuroradiol, 37, pp.1889~1897 (2016)
- Terelak-Borys B, "Ocular ischemic syndrome - a systematic review", Med Sci Monit, 18, pp.RA138~RA144 (2012)
- Stevens WD, "Retinal and optic nerve degeneration after chronic carotid ligation: time course and role of light exposure", Stroke, 33, pp.1107~1112 (2002)
- Román GC, "Subcortical ischaemic vascular dementia", Lancet Neurol, 1, pp.426~436 (2002)
- 한형수, "Water Extract of Triticum aestivum L. and Its Components Demonstrate Protective Effect in a Model of Vascular Dementia", Journal of Medicinal Food, 13(3), pp.572~578 (2010), 한국식품영양과학회
- 임선하, "Hot Water Extract of Wheat Bran Attenuates White Matter Injury in a Rat Model of Vascular Dementia", Preventive Nutrition and Food Science, 19(3), pp.145~155 (2014), 한국식품영양과학회[DOI]
- Fincher GB, "Chemical and physical properties of an arabinogalactan-peptide from wheat endosperm", Biochem J, 139, pp.535~545 (1974)
- Van den Bulck K, "Isolation of cereal arabinogalactan-peptides and structural comparison of their carbohydrate and peptide moieties", J Cereal Sci, 41, pp.59~67 (2005)
- 임선하, "Apple pectin, a dietary fiber, ameliorates myocardial injury by inhibiting apoptosis in a rat model of ischemia", reperfusion, 2014, pp.8(4), 391~397[DOI]
- Nishimura N, "Pectin and high-amylose maize starch increase caecal hydrogen production and relieve hepatic ischaemia-reperfusion injury in rats", Br J Nutr, 107, pp.485~492 (2012)
- Wakita H, "Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study", Acta Neuropathol, 87, pp.484~492 (1994)
- Farkas E, "Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain", Acta Neuropathol, 108, pp.57~64 (2004)
- Tykhomyrov AA, "Glial fibrillary acidic protein (GFAP): on the 45th anniversary of its discovery", Neurophysiology, 48, pp.54~71 (2016)
- Imai Y, "Intracellular signaling in M-CSF-induced microglia activation: role of Iba1", Glia, 40, pp.164~174 (2002)
- Farkas E, "Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases", Brain Res Rev, 54, pp.162~180 (2007)
- López-Valdés HE, "The role of neuroinflammation in age-related dementias", Rev Invest Clin, 68, pp.40~48 (2016)
- Rosenberg GA, "Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment", Stroke, 45, pp.1531~1538 (2014)
- Liu Z, "Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke", Prog Neurobiol, 144, pp.103~120 (2016)
- Saggu R, "Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia", Acta Neuropathol Commun, 4, pp.76~ (2016)
- McDougal DH, "Autonomic control of the eye", Compr Physiol, 5, pp.439~473 (2015)
- Lavinsky D, "Chronic bilateral common carotid artery occlusion: a model for ocular ischemic syndrome in the rat", Graefes Arch Clin Exp Ophthalmol, 244, pp.199~204 (2006)
- Gunes A, "Vision loss and RNFL thinning after internal carotid arter occlusion and middle cerebral artery infarction", Acta Inform Med, 22, pp.413~414 (2014)
- Klijn CJ, "Haemodynamic stroke: clinical features, prognosis, and management", Lancet Neurol, 9, pp.1008~1017 (2010)
- Pretegiani E, "Visual system involvement in CADASIL", J Stroke Cerebrovasc Dis, 22, pp.1377~1384 (2013)
- Parisi V, "Reduction of optic nerve fiber layer thickness in CADASIL", Eur J Neurol, 14, pp.627~631 (2007)
- Rufa A, "Typical pathological changes of CADASIL in the optic nerve", Neurol Sci, 26, pp.271~274 (2005)
- Fabri M, "Functional topography of the corpus callosum investigated by DTI and fMRI", World J Radiol, 6, pp.895~906 (2014)
- Paul LK, "Learning and memory in individuals with agenesis of the corpus callosum", Neuropsychologia, 86, pp.183~192 (2016)
- Tomimoto H, "Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia", J Neurol, 251, pp.398~406 (2004)
- Jung WB, "Cortical atrophy, reduced integrity of white matter and cognitive impairment in subcortical vascular dementia of Binswanger type", Psychiatry Clin Neurosci, 68, pp.821~832 (2014)
- Lin L, "Microstructural white matter abnormalities and cognitive dysfunction in subcortical ischemic vascular disease: an atlas-based diffusion tensor analysis study", J Mol Neurosci, 56, pp.363~370 (2015)
- Best T, "Acute effects of a dietary non-starch polysaccharide supplement on cognitive performance in healthy middle-aged adults", Nutr Neurosci, 18, pp.76~86 (2015)
- Lim SH, "Plant-based foods containing cell wall polysaccharides rich in specific active monosaccharides protect against myocardial injury in rat myocardial infarction models", Sci Rep, 6, pp.38728~ (2016)
- Zhang P, "L-arabinose release from arabinoxylan and arabinogalactan under potential gastric acidities", Cereal Chem, 80, pp.252~254 (2003)
- Bach Knudsen KE, "Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health", Adv Nutr, 6, pp.206~213 (2015)
- Koropatkin NM, "How glycan metabolism shapes the human gut microbiota", Nat Rev Microbiol, 10, pp.323~335 (2012)
- Yano JM, "Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis", Cell, 161, pp.264~276 (2015)
- Fitzpatrick A, "Larch arabinogalactan: a novel and multifunctional natural product", Agro Food Ind Hi Tech, 15, pp.30~32 (2004)
- Dion C, "Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials", Nutr Metab (Lond), 13, pp.28~ (2016)
- Groman EV, "Arabinogalactan for hepatic drug delivery", Bioconjug Chem, 5, pp.547~556 (1994)
- Robinson RR, "Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects", J Am Coll Nutr, 20, pp.279~285 (2001)
- Nair AB, "A simple practice guide for dose conversion between animals and human", J Basic Clin Pharm, 7, pp.27~31 (2016)